Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News | Left Atrial Appendage (LAA) Occluders

August 21, 2020 — According to a report published by Research Dive, the rising number of patients suffering from atrial ...

Home August 21, 2020
Home
In February 2020, the U.S. Food and Drug Administration (FDA) cleared artificial intelligence software to assist in the acquisition of cardiac ultrasound images. The Caption Guidance software from Caption Health is an accessory to compatible diagnostic ultrasound systems and uses artificial intelligence to help the user capture images of a patient’s heart that are of acceptable diagnostic quality. It is aimed at point of care ultrasound (POCUS) exams, where users may not be regular sonographers.
Feature | Artificial Intelligence | Dave Fornell, Editor

The No. 1 overarching hot topic at all the medical conferences over the past couple years has been artificial ...

Home August 18, 2020
Home
News | Mobile C-Arms

August 18, 2020 — Ziehm Imaging announces the acquisition of Therenva, a French-based developer of planning and imaging ...

Home August 18, 2020
Home
News | Heart Failure

 


August 17, 2020 — Pupil size predicts death and hospital readmission in patients with heart failure, according to r ...

Home August 17, 2020
Home
DAIC magazine goes all digital
Feature

Dear Valued Reader,


As the work environment rapidly changes due to the COVID-19 panademic, Diagnostic and ...

Home August 17, 2020
Home
News | Cardiovascular Education | Dave Fornell, Editor

All medical conferences moved to a virtual meeting format due to COVID-19 this year, and there has been apprehension ...

Home August 14, 2020
Home
News | Heart Valve Technology

August 12, 2020 — A national survey conducted by the patient advocacy group Heart-Valve-Surgery.com with support by ...

Home August 12, 2020
Home
News | Left Atrial Appendage (LAA) Occluders

August 6, 2020 – Conformal Medical Inc. announced it secured $85 million in Series C financing to support the company’s ...

Home August 06, 2020
Home
News | Heart Valve Technology

August 5, 2020 – Minneapolis-based CardioMech AS, a medical device company developing a transfemoral, transseptally ...

Home August 05, 2020
Home
News | Remote Monitoring

August 5, 2020 – NorthShore University HealthSystem , Carnegie Mellon University and physIQ are collaborating on a multi ...

Home August 05, 2020
Home
Abiomed Impella is now authorized to treat critical ICU COVID-19 patients on ECMO who develop pulmonary edema or need cardiac decompensation from myocarditis. #COVID19 #SARScov2 #Impella
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

August 5, 2020 — The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) this week for ...

Home August 05, 2020
Home
News | Heart Failure

August 4, 2020 - More than three years after a clinical trial was prematurely ended for failing to show progress in ...

Home August 04, 2020
Home
News | Cardiogenic Shock

August 3, 2020 — A three-year, investigator-led, prospective study of Japanese patients who received an Impella heart ...

Home August 03, 2020
Home
Two of the top pieces of content in July included the FDA clearance for the new Watchman FLX left atrial appendage occluder (left), which includes a video interview with one of the trial investigators. COVID-19 content remained among the top content in July, and one story explained the odd pattern of cardiac cell death in COVID-19 patient autopsies. 
Feature | Dave Fornell, Editor

August 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) mag ...

Home August 03, 2020
Home
Subscribe Now